Contact Us
Drug Search Results
More Filters [+]

Metaraminol

Alternative Names: metaraminol, aramine
Latest Update: 2025-01-25
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ADRA1A Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Brazil | India | Ireland | Italy | New Zealand | Pakistan | Saudi Arabia | Sri Lanka | Taiwan | Turkey | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Zhejiang University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Metaraminol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Acute Respiratory Distress Syndrome|Acute Lung Injury|Respiratory Distress Syndrome, Newborn|Hypertension|Cardiac Output, High|Pregnancy Outcomes|Cesarean Section|Stroke|Syncope|Bradycardia|Acidosis, Lactic|Hypotension

Phase 3: Pre-Eclampsia|Pregnancy Outcomes|Hypotension

Phase 2: Hypotension

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ChiCTR2400092788

N/A

Recruiting

Heart Failure|Hypotension

2026-12-31

ChiCTR2400091036

N/A

Not yet recruiting

Cesarean Section|Hypotension

2025-06-01

HEAD-START 2

N/A

Not yet recruiting

Stroke

2024-09-30

Effect of different administration modes of metaraminol on shivering and hypothermia after lumbar anesthesia during cesarean section

N/A

Not yet recruiting

Hypothermia|Cesarean Section

2024-03-31

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions